Jianguo Wang
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 5
- Cancer, Hypoxia, and Metabolism 5
- Immunology top 5%
- Immune cells in cancer 5
- Oncology top 5%
- Peptidase Inhibition and Analysis 5
- Cancer Immunotherapy and Biomarkers 5
- Hepatology top 5%
- Molecular Biology top 10%
- RNA modifications and cancer 9
- RNA Interference and Gene Delivery 4
- Cited by
- Cancer ResearchImmunologyOncology
- Partner nations
- ChinaUnited StatesMadagascar
In The Last Decade
Jianguo Wang
47 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Cancer Research 496
- Immunology 605
- Oncology 606
- Hepatology 127
- Molecular Biology 1.1k
Countries citing papers authored by Jianguo Wang
This map shows the geographic impact of Jianguo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianguo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianguo Wang more than expected).
Fields of papers citing papers by Jianguo Wang
This network shows the impact of papers produced by Jianguo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianguo Wang. The network helps show where Jianguo Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianguo Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 10 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 33 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 8 | |
| 10 | 2022 | 12 | |
| 11 | 2021 | 10 | |
| 12 | 2021 | 26 | |
| 13 | 2021 | 30 | |
| 14 | 2018 | 88 | |
| 15 | 2018 | 46 | |
| 16 | 2017 | 54 | |
| 17 | EDITORIAL : Toll-Like Receptors and Src-Family Kinases in Atherosclerosis : Focus on Macrophages | 2015 | 1 |
| 18 | [Reversal of adriamycin resistance by digoxin in human breast cancer cell line MCF-7/adriamycin and its mechanism]. | 2015 | 2 |
| 19 | 2015 | 18 | |
| 20 | 2013 | 10 |
About Jianguo Wang
Jianguo Wang is a scholar working on Cancer Research, Hepatology and Oncology, having authored 49 papers that have together received 2.0k indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (5 papers), Peptidase Inhibition and Analysis (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immune cells in cancer (5 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Cancer Research (496 citations), Immunology (605 citations) and Oncology (606 citations). Jianguo Wang has collaborated with scholars based in China, United States and Madagascar. Frequent co-authors include Xiao Xu, Di Lu, Xiaonan Xiang, Xuyong Wei, Haiyang Xie, Hangxiang Wang, Shusen Zheng, Shusen Zheng, Lin Zhou and Zhikun Liu. Their work appears in journals such as Nature, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.